Literature DB >> 16790421

Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.

Marina K Ayrapetov1, Yue-Hao Wang, Xiaofeng Lin, Xianfeng Gu, Keykavous Parang, Gongqin Sun.   

Abstract

Src protein-tyrosine kinase contains a myristoylation motif, a unique region, an Src homology (SH) 3 domain, an SH2 domain, a catalytic domain, and a C-terminal tail. The C-terminal tail contains a Tyr residue, Tyr527. Phosphorylation of Tyr527 triggers Src inactivation, caused by Tyr(P)527 binding to the SH2 domain. In this study, we demonstrated that a conformational contribution, not affinity, is the predominant force for the intramolecular SH2-Tyr(P)527 binding, and we characterized the structural basis for this conformational contribution. First, a phosphopeptide mimicking the C-terminal tail is an 80-fold weaker ligand than the optimal phosphopeptide, pYEEI, and similar to a phosphopeptide containing three Ala residues following Tyr(P) in binding to the Src SH2 domain. Second, the SH2-Tyr(P)527 binding is largely independent of the amino acid sequence surrounding Tyr(P)527, and only slightly decreased by an inactivating mutation in the SH2 domain. Furthermore, even the unphosphorylated C-terminal tail with the sequence of YEEI suppresses Src activity by binding to the SH2 domain. These experiments demonstrate that very weak affinity is sufficient for the SH2-Tyr(P)527 binding in Src inactivation. Third, the effective intramolecular SH2-Tyr(P)527 binding is attributed to a conformational contribution that requires residues Trp260 and Leu255. Although the SH3 domain is essential for Src inactivation by Tyr(P)527, it does not contribute to the SH2-Tyr(P)527 binding. These findings suggest a conformation-based Src inactivation model, which provides a unifying framework for understanding Src activation by a variety of mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790421     DOI: 10.1074/jbc.M604219200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  PTMScout, a Web resource for analysis of high throughput post-translational proteomics studies.

Authors:  Kristen M Naegle; Melissa Gymrek; Brian A Joughin; Joel P Wagner; Roy E Welsch; Michael B Yaffe; Douglas A Lauffenburger; Forest M White
Journal:  Mol Cell Proteomics       Date:  2010-07-14       Impact factor: 5.911

2.  On the importance of a funneled energy landscape for the assembly and regulation of multidomain Src tyrosine kinases.

Authors:  José D Faraldo-Gómez; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

3.  Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.

Authors:  Sujata Chakraborty; Takayuki Inukai; Linglan Fang; Martin Golkowski; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

4.  Serendipitous discovery of a novel protein signaling mechanism in heart failure.

Authors:  Andrea M Vitello; Yanmei Du; Peter M Buttrick; Lori A Walker
Journal:  Biochem Biophys Res Commun       Date:  2012-04-07       Impact factor: 3.575

5.  Conformational buffering underlies functional selection in intrinsically disordered protein regions.

Authors:  Nicolás S González-Foutel; Juliana Glavina; Wade M Borcherds; Matías Safranchik; Susana Barrera-Vilarmau; Amin Sagar; Alejandro Estaña; Amelie Barozet; Nicolás A Garrone; Gregorio Fernandez-Ballester; Clara Blanes-Mira; Ignacio E Sánchez; Gonzalo de Prat-Gay; Juan Cortés; Pau Bernadó; Rohit V Pappu; Alex S Holehouse; Gary W Daughdrill; Lucía B Chemes
Journal:  Nat Struct Mol Biol       Date:  2022-08-10       Impact factor: 18.361

Review 6.  The Y's that bind: negative regulators of Src family kinase activity in platelets.

Authors:  D K Newman
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

7.  A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.

Authors:  Ernest Turro; Daniel Greene; Anouck Wijgaerts; Chantal Thys; Claire Lentaigne; Tadbir K Bariana; Sarah K Westbury; Anne M Kelly; Dominik Selleslag; Jonathan C Stephens; Sofia Papadia; Ilenia Simeoni; Christopher J Penkett; Sofie Ashford; Antony Attwood; Steve Austin; Tamam Bakchoul; Peter Collins; Sri V V Deevi; Rémi Favier; Myrto Kostadima; Michele P Lambert; Mary Mathias; Carolyn M Millar; Kathelijne Peerlinck; David J Perry; Sol Schulman; Deborah Whitehorn; Christine Wittevrongel; Marc De Maeyer; Augusto Rendon; Keith Gomez; Wendy N Erber; Andrew D Mumford; Paquita Nurden; Kathleen Stirrups; John R Bradley; F Lucy Raymond; Michael A Laffan; Chris Van Geet; Sylvia Richardson; Kathleen Freson; Willem H Ouwehand
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

8.  Active site profiling reveals coupling between domains in SRC-family kinases.

Authors:  Ratika Krishnamurty; Jennifer L Brigham; Stephen E Leonard; Pratistha Ranjitkar; Eric T Larson; Edward J Dale; Ethan A Merritt; Dustin J Maly
Journal:  Nat Chem Biol       Date:  2012-11-11       Impact factor: 15.040

9.  Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.

Authors:  Stephen E Leonard; A C Register; Ratika Krishnamurty; Gabriel J Brighty; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2014-07-02       Impact factor: 5.100

10.  SH2-catalytic domain linker heterogeneity influences allosteric coupling across the SFK family.

Authors:  A C Register; Stephen E Leonard; Dustin J Maly
Journal:  Biochemistry       Date:  2014-10-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.